Loading markets…

Revolution Medicines, Inc. (RVMD) forecast

Revolution Medicines, Inc. (RVMD) forecast: price $187.91, trailing P/E -21.93, forward P/E 36.61. How to read the street's path.

$187.91Price
$40.27BMarket cap
-21.93P/E ?
36.61Forward P/E ?
0.00%Dividend yield ?

The live RVMD price is $187.91. Trailing P/E is -21.93 and forward P/E is 36.61. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the RVMD forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full RVMD quote · Dividends · Price prediction · Academy

Questions

What is RVMD's forward P/E?

The latest forward P/E on Stocklytics is 36.61, against a trailing P/E of -21.93 and a price of $187.91.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.